Citation Impact
Citing Papers
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
2006
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
2015
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Glutathione Depletion Is Necessary for Apoptosis in Lymphoid Cells Independent of Reactive Oxygen Species Formation
2007
An advanced human in vitro co-culture model for translocation studies across the placental barrier
2018
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor–null mice by intestinal‐specific farnesoid X receptor reactivation
2014
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Placental control of drug delivery
2016
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Cell Culture Systems for Hepatitis C Virus
2013
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Chlorpyrifos modifies the expression of genes involved in human placental function
2012
Tissue-specific actions of FXR in metabolism and cancer
2014
Secondary bile acids: an underrecognized cause of colon cancer
2014
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition
2010
Burden of liver diseases in the world
2018 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Intestinal transport and metabolism of bile acids
2014
Evidence for Drug Release from a Metalla‐Cage Delivery Vector Following Cellular Internalisation
2009
Bile acids in the colon, from healthy to cytotoxic molecules
2012
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
2017
Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase Antagonists
2012
COVID-19: A promising cure for the global panic
2020 Standout
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
2009
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Willmar Schwabe Award 2006: Antiplasmodial and Antitumor Activity of Artemisinin - From Bench to Bedside
2007
The Role of Canalicular ABC Transporters in Cholestasis
2014
Beyond intestinal soap—bile acids in metabolic control
2014
Gut microbiome and health: mechanistic insights
2022 Standout
Hepatobiliary transporter expression in human hepatocellular carcinoma
2005
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Intracellular Signaling by Bile Acids
2014
Genome-wide association meta-analysis for total serum bilirubin levels
2009
Fluorescent Cisplatin Analogues and Cytotoxic Activity
2009
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
2009
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
2019
Cholic acid–carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds
2003
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
2010
Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications
2007
Deep learning in histopathology: the path to the clinic
2021 Standout
Novel insight into mechanisms of cholestatic liver injury
2012
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid
2005
Beyond malaria: The inhibition of viruses by artemisinin-type compounds
2018
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
2012
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Oxidative stress in chronic kidney disease
2018 Standout
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
2010
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases
2015
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
2013
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
A Biliary HCO3 − Umbrella Constitutes A Protective Mechanism Against Bile Acid–Induced Injury in Human Cholangiocytes
2011
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
New metal complexes as potential therapeutics
2003
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
2006
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model
2016
Enterohepatic bile salt transporters in normal physiology and liver disease
2003
Primary sclerosing cholangitis – a comprehensive review
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Iron Catalysis in Organic Synthesis
2015 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis
2016
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Development of anin SilicoProfiler for Mitochondrial Toxicity
2015
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Synthesis and Asymmetric Resolution of α-Azido-peroxides
2013
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
2007
Fundamentals of cancer metabolism
2016 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis
2021
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Cell Culture Models for Hepatitis E Virus
2019
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum−Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12
2007
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
2013
Inflammatory Bowel Disease
2010 Standout
Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
2015
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Interactions between bile salts, gut microbiota, and hepatic innate immunity
2017
Clathrin Mediates Infectious Hepatitis C Virus Particle Egress
2015
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Intrahepatic cholestasis of pregnancy
2009
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Metal–Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal–Organic Materials
2012 Standout
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Pharmacogenetics of Anti-HIV Drugs
2007
Works of Óscar Briz being referenced
MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression
2019
Characterization of the Role of ABCG2 as a Bile Acid Transporter in Liver and Placenta
2011
Bile-acid-induced cell injury and protection
2009
Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway
2003
OATP8/1B3-mediated Cotransport of Bile Acids and Glutathione
2006
Carriers Involved in Targeting the Cytostatic Bile Acid-Cisplatin Derivativescis-Diammine-chloro-cholylglycinate-platinum(II) andcis-Diammine-bisursodeoxycholate-platinum(II) toward Liver Cells
2002
Expression in Human Trophoblast and Choriocarcinoma Cell Lines, BeWo, Jeg-3 and JAr of Genes Involved in the Hepatobiliary-like Excretory Function of the Placenta
2006
Inhibition of the intestinal absorption of bile acids using cationic derivatives: Mechanism and repercussions
2006
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy
2005
Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
2010
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
2016
Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps
2006
Usefulness of Liposomes Loaded with Cytostatic Bile Acid Derivatives to Circumvent Chemotherapy Resistance of Enterohepatic Tumors
2003
Maternal cholestasis during pregnancy programs metabolic disease in offspring
2013
Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle
2012
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds
2013
A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene ( BLVRA) results in accumulation of biliverdin during episodes of cholestasis
2011
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system
2005
Proapoptotic Effect on Normal and Tumor Intestinal Cells of Cytostatic Drugs with Enterohepatic Organotropism
2005
Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development
2013
Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-Independent Up-Regulation of ABC Proteins
2012
Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin
2003
Overcoming cisplatin resistance in vitro by a free and liposome‐encapsulated bile acid derivative: BAMET‐R2
2000
Overcoming cisplatin resistancein vitro by a free and liposome-encapsulated bile acid derivative: BAMET-R2
2000